Related Experiment Video
Updated: Jul 20, 2026
08:41
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Published on: October 27, 2014
Drug interactions with the taxanes: clinical implications
1Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, Tucson, AZ 85724-5024, USA. abaker@azcc.arizona.edu
Cancer Treatment Reviews
|September 8, 2001
Summary
Clinically significant drug interactions with taxanes like paclitaxel can occur, impacting treatment efficacy and toxicity. Careful administration timing and dose adjustments are crucial when combining taxanes with agents like anthracyclines, cisplatin, or anticonvulsants.
Area of Science:
- Oncology
- Pharmacology
- Clinical Pharmacy
Background:
- Taxanes (paclitaxel, docetaxel) are potent antitumor agents.
- Drug interactions with taxanes can be sequence/schedule-dependent.
- Hepatic metabolism via cytochrome P450 leads to pharmacokinetic interactions.
Purpose of the Study:
- To identify clinically significant drug interactions with taxanes.
- To provide guidance on managing these interactions to optimize patient outcomes.
Main Methods:
- Comprehensive literature search of Medline database.
- Identification of clinically important drug-drug interactions with taxanes.
Main Results:
- Significant interactions identified with carboplatin, cisplatin, doxorubicin, docetaxel, epirubicin, and anticonvulsants.
- Specific administration sequences recommended for anthracyclines and cisplatin to mitigate toxicity and maintain efficacy.
- Concurrent anticonvulsant use may necessitate paclitaxel dose adjustment due to P450 enzyme induction.
Conclusions:
- Paclitaxel interactions with doxorubicin, cisplatin, and anticonvulsants (phenytoin, carbamazepine, phenobarbital) are clinically significant.
- Management strategies are essential to prevent adverse events and ensure therapeutic effectiveness.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...